Predict your next investment

Corporation
z-comm.com

See what CB Insights has to offer

Investments

1

About Zehnder Communications

Zehnder Communications is a fully integrated advertising agency providing a wide range of services including strategic marketing, public relations, media placement, creative services, interactive design and programming.

Zehnder Communications Headquarter Location

650 Poydras Street Suite 2450

New Orleans, Louisiana, 70130,

United States

504-558-7778

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Zehnder Communications News

Microbiome Therapeutics prepares to launch ‘microbiome modulator’

Nov 6, 2017

By Stephen Daniells © Getty Images / Nastco After successfully completing a Series B financing, Microbiome Therapeutics is gearing up for the launch of a ‘microbiome modulator’ product designed to help balance the microbiome and support healthy metabolism. The product, which is a blend of prebiotics, including fermentable fiber (beta-glucan and inulin) and polyphenol antioxidants in a drink mix, will launch in 2018, said the company. A brand name is still under investigation and should be selected soon, a spokesperson for the company told us. “This product is a scientific formulation of natural ingredients designed to support a balanced GI microbiome and promote metabolic health, in an easy-to-use, flavorful drink mix,” ​said Dale Pfost, acting CEO of MicroBiome Therapeutics. “Our two clinical trials, conducted at the Pennington Biomedical Research Center and reported in peer-reviewed publications, demonstrated its benefits in helping to manage hunger, maintain healthy blood sugar levels and promote regularity.”​ The spokesperson added that the dietary supplement product will initially launch via e-commerce supported by social media conducted in partnership with New Orleans-based advertising agency Zehnder Communications, plus a network of registered dietitians and certified diabetes educators. Retail distribution will be built out in the next phase. Financing​ The Series B financing raised approximately $1 million. New and existing investors included Lagniappe Angels, NO/LA Angel Network, Zehnder Communications and other private investors. “With MicroBiome Therapeutics, we saw a unique opportunity to apply our product launch expertise in support of an exciting, first-in-class product from a leading science-based company,”​ said Jeremy Hunnewell, CFO and Business Strategist for Zehnder Communications. “We believe our expertise, along with our integrative and analytical approaches, will enable MBT to inform and educate consumers about this exciting new type of health-promoting dietary supplement. Our investment reinforces our commitment to making a difference by playing a part in the microbiome revolution.” ​Hunnewell will be joining the board of directors of MBT. Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

Zehnder Communications Investments

1 Investments

Zehnder Communications has made 1 investments. Their latest investment was in MicroBiome Therapeutics as part of their Series B on November 11, 2017.

CBI Logo

Zehnder Communications Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/1/2017

Series B

MicroBiome Therapeutics

$1M

Yes

Lagniappe Angels, NO/LA Angel Network, and Undisclosed Investors

4

Date

11/1/2017

Round

Series B

Company

MicroBiome Therapeutics

Amount

$1M

New?

Yes

Co-Investors

Lagniappe Angels, NO/LA Angel Network, and Undisclosed Investors

Sources

4

Zehnder Communications Team

1 Team Member

Zehnder Communications has 1 team member, including current Chief Financial Officer, Jeremy Hunnewell.

Name

Work History

Title

Status

Jeremy Hunnewell

Chief Financial Officer

Current

Name

Jeremy Hunnewell

Work History

Title

Chief Financial Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.